+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
ID07466784

Improving Care and Outcomes for Emergency Department Patients with Opioid Poisoning or Dependence Across Canada

Led by University of British Columbia · Updated on 2026-03-12

7200

Participants Needed

1

Research Sites

22 weeks

Total Duration

AI-Summary

What This Trial Is About

Opioid poisoning is a major cause of preventable death and lost years of life in Canada, driven mainly by potent synthetic opioids like fentanyl. Emergency departments, which operate 247 and are frequently visited by people who use drugs, provide critical opportunities to treat opioid poisoning and initiate care. This observational study aims to create a nationwide Canadian Emergency Department Research Network CEDRN Opioid Registry to collect and harmonize data on patients presenting with opioid poisoning, opioid dependence, or polysubstance use across multiple sites. The goal is to generate evidence to guide clinical practice and develop a tool to predict risk of death within 60 days after an emergency visit. The study will identify patients of all ages presenting to emergency departments with suspected or confirmed opioid poisoning by screening electronic health records for specific diagnoses and medication orders related to opioids and opioid use disorder. Data collected will include patient demographics, clinical signs, treatments given in prehospital and hospital settings, and patient outcomes. The registry will capture the full patient journey from ambulance arrival to hospital discharge. Researchers will analyze variations in care and outcomes, assess safety and effectiveness of treatments such as naloxone and opioid agonist therapy, and develop a risk prediction rule to prioritize high-risk patients. Participants electronic health records will be reviewed and linked to administrative data to track outcomes such as retention on opioid agonist therapy and mortality at multiple time points up to 12 months. The study will monitor treatments like naloxone administration, hospital discharge status, and mortality. Knowledge users, patients with lived experience, and Indigenous advisors will help guide the research and dissemination of findings. The study plans to improve healthcare delivery, support health system sustainability, and inform clinical decision-making for patients with opioid poisoning nationwide.

CONDITIONS

Brief Title

CEDRN: Opioid Registry

Research Team

J

Jeffrey P Hau, MSc

V

Vi Ho, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here